Clinical trial
Therapy for Chronic Cold Agglutinin Disease
NCT00373594 · University of Bergen, Other · Completed
Key facts
| NCT number | NCT00373594 |
|---|---|
| Title | Therapy for Chronic Cold Agglutinin Disease |
| Official title | Therapy for Chronic Cold Agglutinin Disease: A Prospective, Non-randomized International Multicentre Study on the Safety and Efficacy of Rituximab in Combination With Fludarabine. |
| Lead sponsor | University of Bergen, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cold Agglutinin Disease |
| Intervention type | Drug |
| Interventions | Rituximab, Fludarabine |
| Enrollment | 30 |
| Start date | Jun 1, 2005 |
| Primary completion | Apr 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Sep 8, 2006 |
| Last update posted | Jun 22, 2010 |
| Countries | Norway, Russia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: